Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to $1.6 million.

  • Incannex Healthcare's Total Current Liabilities fell 82.15% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 82.15%. This contributed to the annual value of $7.0 million for FY2025, which is 24.27% up from last year.
  • Incannex Healthcare's Total Current Liabilities amounted to $1.6 million in Q3 2025, which was down 76.40% from $7.0 million recorded in Q2 2025.
  • Over the past 5 years, Incannex Healthcare's Total Current Liabilities peaked at $9.2 million during Q3 2024, and registered a low of $1.6 million during Q3 2025.
  • Over the past 3 years, Incannex Healthcare's median Total Current Liabilities value was $5.7 million (recorded in 2024), while the average stood at $5.3 million.
  • Data for Incannex Healthcare's Total Current Liabilities shows a peak YoY increase of 157.26% (in 2025) and a maximum YoY decrease of 82.15% (in 2025) over the last 5 years.
  • Over the past 3 years, Incannex Healthcare's Total Current Liabilities (Quarterly) stood at $3.2 million in 2023, then spiked by 83.30% to $5.8 million in 2024, then slumped by 82.15% to $1.6 million in 2025.
  • Its Total Current Liabilities stands at $1.6 million for Q3 2025, versus $7.0 million for Q2 2025 and $7.4 million for Q1 2025.